Search

You searched for "Oculus"

1008 results found

My Top Five: Innovative approaches to dry AMD

2 February 2024 | | AMD
Age-related macular degeneration (AMD) is one of the leading causes of irreversible blindness in the developing world with its prevalence rising alongside age. In societies characterised by ageing populations, it is imperative we explore more effective treatment to alleviate the...

My Top Five: Eye-related webinars during lockdown

12 August 2020 | | COVID-19
1. Alcon Experience Academy The Alcon Experience Academy ran a non-promotional educational series from 12 May to 23 June 2020. Being mildly biased as a junior trainee, this has to be rated by far the best series due to its...

Childhood glaucoma

1 February 2019 | | Glaucoma, Ophthalmology, Paediatric Ophthalmology / Strabismus
When a child is given a diagnosis of glaucoma, the impact upon that child and their family is enormous; equivalent to the diagnosis of a cancer [14]. This article outlines the knowledge, techniques and approaches that offer solutions to the...

An update on inherited retinal disorders (part 2): Approaches to therapy for IRDs

1 December 2016 | | Retina / Uvea / Vitreous
Part 1 of this topic can be found here There are currently no proven cures for inherited retinal disease (IRD). However, multiple avenues of research are being investigated to better understand disease mechanisms and trial potential therapies that may slow...

A closer look at the new wave of glaucoma surgery – radical or old school?

1 October 2016 | | Glaucoma
Glaucoma is a challenging condition to treat because the exact pathophysiology remains unclear and the only readily modifiable factor is the intraocular pressure (IOP). Additionally, most glaucoma patients are completely asymptomatic, yet are often subjected to lifelong medical therapy. The...

The role of inflammation in the pathophysiology of DMO

1 February 2016 | | Retina / Uvea / Vitreous
Diabetic macular oedema (DMO) is a major cause of visual loss in diabetes, with a complex multifactorial pathogenesis. In the UK alone it is estimated that there are nearly 2.5 million diabetic patients aged over 12 years. Approximately 65,000 of...

Coming to terms with AI

1 August 2019 | | Ophthalmology, Imaging, Retina / Uvea / Vitreous, Glaucoma
A machine might be called intelligent if its response to questions could convince a person that it was human, a test proposed by Alan Turing in 1950 [1]. The author considers potential applications of artificial intelligence (AI) using machine learning...

The paediatric cataract: an overview of the diagnosis and management

5 August 2020 | | Ophthalmology, Cataract and Refractive
In this second article (see first article here), Samuel Aryee and Rhys Dumont Jones review the challenges involved in managing this condition. Examination and diagnosis Cataracts in children can appear in a variety of forms, each presenting in a different...

Effect of the COVID-19 Urgent Eyecare Service on patient referrals to general practitioners and Hospital Eye Service

28 April 2023 | | COVID-19, Emergency Ophthalmology, ONLINE EXCLUSIVE ARTICLES
The COVID-19 Urgent Eyecare Services (CUES) was developed to relieve the demands of hospital ophthalmology, aiming to allow patients to have remote consultations and be managed by community optometric practice. This was because access to Hospital Eye Service (HES) Ophthalmic...

RCOphth Annual Congress 2022 - Preview

19 May 2022
Eye News previews the RCOphth Annual Congress 2022, as we look forward to the return of an in-person Congress for the first time since 2019. Follow updates and key events here.

RCOphth Annual Congress - Day 3

25 May 2022 |
Follow live updates and key highlights from Day 3 of the RCOphth Annual Congress.

What's trending Apr/May 2022

5 April 2022 | | Ophthalmology, Optometry
A round-up of the eye-related hot topics that have been trending over the last few weeks. #ArgusI #ArgusII #bioniceye #retinitispigmentosa #SecondSight Remember Argus I & Argus II? Its star burned bright, touted as the future of treatment for retinitis pigmentosa....